 Christine Simecka Morgan
Concepts (83)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Locomotion | 3 | 2021 | 85 | 0.340 |
Why?
| | Sigmodontinae | 1 | 2015 | 1 | 0.250 |
Why?
| | Lymphoma, T-Cell, Cutaneous | 1 | 2015 | 12 | 0.250 |
Why?
| | Ear Auricle | 1 | 2015 | 6 | 0.250 |
Why?
| | Ear Neoplasms | 1 | 2015 | 10 | 0.240 |
Why?
| | Water Deprivation | 1 | 2013 | 5 | 0.210 |
Why?
| | Animal Husbandry | 1 | 2013 | 12 | 0.200 |
Why?
| | Oligosaccharides | 1 | 2022 | 34 | 0.190 |
Why?
| | Laboratories | 1 | 2021 | 21 | 0.180 |
Why?
| | Milk, Human | 1 | 2022 | 105 | 0.180 |
Why?
| | Skin Neoplasms | 1 | 2015 | 500 | 0.170 |
Why?
| | Motor Activity | 1 | 2021 | 224 | 0.160 |
Why?
| | Mice | 4 | 2022 | 5965 | 0.160 |
Why?
| | Benzeneacetamides | 1 | 2019 | 12 | 0.150 |
Why?
| | Glutaminase | 1 | 2019 | 18 | 0.150 |
Why?
| | Thiadiazoles | 1 | 2019 | 18 | 0.150 |
Why?
| | Bile Ducts | 1 | 2019 | 50 | 0.150 |
Why?
| | Psychotropic Drugs | 1 | 2019 | 77 | 0.150 |
Why?
| | Benzodioxoles | 1 | 2019 | 43 | 0.150 |
Why?
| | Pyrrolidines | 1 | 2019 | 69 | 0.150 |
Why?
| | Radiation Tolerance | 1 | 2019 | 84 | 0.140 |
Why?
| | Antimetabolites, Antineoplastic | 1 | 2017 | 39 | 0.140 |
Why?
| | Dendrites | 1 | 2017 | 30 | 0.140 |
Why?
| | Cytarabine | 1 | 2017 | 42 | 0.140 |
Why?
| | Sex Characteristics | 1 | 2019 | 198 | 0.140 |
Why?
| | Heart Rate | 1 | 2019 | 319 | 0.140 |
Why?
| | Methotrexate | 1 | 2017 | 77 | 0.140 |
Why?
| | Methamphetamine | 1 | 2019 | 198 | 0.130 |
Why?
| | Animals | 9 | 2022 | 13523 | 0.130 |
Why?
| | Blood Pressure | 1 | 2019 | 534 | 0.130 |
Why?
| | Hippocampus | 1 | 2017 | 201 | 0.120 |
Why?
| | Cognition | 1 | 2017 | 331 | 0.120 |
Why?
| | Liver | 1 | 2019 | 1159 | 0.100 |
Why?
| | Lung Neoplasms | 1 | 2019 | 636 | 0.100 |
Why?
| | Papio cynocephalus | 1 | 2011 | 1 | 0.090 |
Why?
| | Babesia | 1 | 2011 | 6 | 0.090 |
Why?
| | Animals, Laboratory | 1 | 2011 | 6 | 0.090 |
Why?
| | Monkey Diseases | 1 | 2011 | 4 | 0.090 |
Why?
| | Babesiosis | 1 | 2011 | 7 | 0.090 |
Why?
| | Male | 7 | 2021 | 26696 | 0.070 |
Why?
| | Lymphocytes, Tumor-Infiltrating | 1 | 2015 | 78 | 0.060 |
Why?
| | Biopsy | 1 | 2015 | 604 | 0.050 |
Why?
| | Animals, Outbred Strains | 1 | 2013 | 12 | 0.050 |
Why?
| | Corticosterone | 1 | 2013 | 18 | 0.050 |
Why?
| | Immunohistochemistry | 1 | 2015 | 985 | 0.050 |
Why?
| | Rats | 2 | 2019 | 3202 | 0.050 |
Why?
| | Immunity | 1 | 2022 | 39 | 0.050 |
Why?
| | Intestines | 1 | 2022 | 154 | 0.040 |
Why?
| | Housing, Animal | 1 | 2021 | 18 | 0.040 |
Why?
| | Weight Loss | 1 | 2013 | 249 | 0.040 |
Why?
| | Temperature | 1 | 2021 | 165 | 0.040 |
Why?
| | Gene Expression | 1 | 2022 | 623 | 0.040 |
Why?
| | Adrenergic Uptake Inhibitors | 1 | 2019 | 16 | 0.040 |
Why?
| | Ligation | 1 | 2019 | 61 | 0.040 |
Why?
| | Telemetry | 1 | 2019 | 29 | 0.040 |
Why?
| | Cardiovascular System | 1 | 2019 | 55 | 0.040 |
Why?
| | Rats, Wistar | 1 | 2019 | 194 | 0.040 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2019 | 222 | 0.040 |
Why?
| | Injections, Spinal | 1 | 2017 | 21 | 0.040 |
Why?
| | Glutamine | 1 | 2019 | 176 | 0.040 |
Why?
| | Glutathione | 1 | 2019 | 306 | 0.030 |
Why?
| | Reproducibility of Results | 1 | 2021 | 1214 | 0.030 |
Why?
| | Leukocytes | 1 | 2017 | 61 | 0.030 |
Why?
| | Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2017 | 91 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2019 | 1377 | 0.030 |
Why?
| | Rats, Sprague-Dawley | 1 | 2019 | 1552 | 0.030 |
Why?
| | Cell Line, Tumor | 1 | 2019 | 1436 | 0.030 |
Why?
| | Mice, Inbred C57BL | 1 | 2017 | 1903 | 0.020 |
Why?
| | RNA, Ribosomal, 18S | 1 | 2011 | 7 | 0.020 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2017 | 1031 | 0.020 |
Why?
| | Likelihood Functions | 1 | 2011 | 56 | 0.020 |
Why?
| | DNA Primers | 1 | 2011 | 209 | 0.020 |
Why?
| | Species Specificity | 1 | 2011 | 192 | 0.020 |
Why?
| | Bayes Theorem | 1 | 2011 | 120 | 0.020 |
Why?
| | Models, Genetic | 1 | 2011 | 172 | 0.020 |
Why?
| | Cluster Analysis | 1 | 2011 | 232 | 0.020 |
Why?
| | Sequence Analysis, DNA | 1 | 2011 | 230 | 0.020 |
Why?
| | Phylogeny | 1 | 2011 | 234 | 0.020 |
Why?
| | Base Sequence | 1 | 2011 | 648 | 0.020 |
Why?
| | Polymerase Chain Reaction | 1 | 2011 | 460 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2011 | 792 | 0.020 |
Why?
| | Female | 2 | 2019 | 28105 | 0.020 |
Why?
| | Humans | 2 | 2022 | 52336 | 0.010 |
Why?
|
|
Simecka Morgan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|